Tyle M. Dylan-Hyde
Keine laufenden Positionen mehr
Profil
Tyle M.
Dylan-Hyde was the founder of Taxus Cardium Pharmaceuticals Group, Inc. founded in 2003, where he held the titles of Secretary, Director, General Counsel & EVP.
He also held former positions as Secretary, Director, Chief Business Officer & EVP at Tissue Repair Co. from 2006 to 2014, Director & Chief Business Officer at To Go Brands, Inc. from 2012 to 2013, Secretary, Chief Business Officer & EVP at Aries Ventures, Inc. from 2005 to 2006, Vice President & General Counsel at Collateral Therapeutics, Inc. from 1998 to 2002, Partner at Morrison & Foerster LLP, and Secretary, Chief Business Officer & EVP at Post-Hypothermia Corp.
from 2006 to 2009.
He also served as Chief Legal Officer at CRISPR Therapeutics AG from 2015 to 2018.
Dr. Dylan-Hyde's education includes an undergraduate degree from McGill University, a graduate degree from the University of California, Berkeley, and a doctorate degree from the University of California San Diego.
Ehemalige bekannte Positionen von Tyle M. Dylan-Hyde
| Unternehmen | Position | Ende |
|---|---|---|
| CRISPR THERAPEUTICS AG | General Counsel | 26.03.2018 |
Tissue Repair Co.
 Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Direktor/Vorstandsmitglied | 01.11.2014 |
To Go Brands, Inc.
 To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Part of Cell-nique Corp., To Go Brands, Inc. develops and markets health products. The company is based in San Diego, CA. To Go Brands was acquired by Cell-nique Corp. from Taxus Cardium Pharmaceuticals Group, Inc. on November 18, 2013 for $2.50 million. | Direktor/Vorstandsmitglied | 01.11.2013 |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | General Counsel | 01.07.2009 |
| Aries Ventures, Inc. | General Counsel | 23.01.2006 |
Ausbildung von Tyle M. Dylan-Hyde
| McGill University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
| University of California, Berkeley | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA. | Commercial Services |
| Aries Ventures, Inc. | Finance |
Tissue Repair Co.
Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Health Technology |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Health Technology |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Commercial Services |
To Go Brands, Inc.
To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Part of Cell-nique Corp., To Go Brands, Inc. develops and markets health products. The company is based in San Diego, CA. To Go Brands was acquired by Cell-nique Corp. from Taxus Cardium Pharmaceuticals Group, Inc. on November 18, 2013 for $2.50 million. | Health Technology |
